33 related articles for article (PubMed ID: 11740037)
21. Ignoring puff counts: another shortcoming of the Federal Trade Commission cigarette testing programme.
Kozlowski LT; Whetzel CA; Stellman SD; O'Connor RJ
Tob Control; 2008 Sep; 17 Suppl 1():i6-9. PubMed ID: 18768461
[TBL] [Abstract][Full Text] [Related]
22. Subliminal manipulation of smoking.
Frydman M
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):173-6. PubMed ID: 9216802
[TBL] [Abstract][Full Text] [Related]
23. Historical perspective: the low tar lie.
Shopland DR
Tob Control; 2001; 10 Suppl 1(Suppl 1):i1-3. PubMed ID: 11740037
[No Abstract] [Full Text] [Related]
24. Science, industry, and tobacco harm reduction: a case study of tobacco industry scientists' involvement in the National Cancer Institute's Smoking and Health Program, 1964-1980.
Parascandola M
Public Health Rep; 2005; 120(3):338-49. PubMed ID: 16134578
[No Abstract] [Full Text] [Related]
25. The lightest market in the world: light and mild cigarettes in Japan.
Assunta M; Chapman S
Nicotine Tob Res; 2008 May; 10(5):803-10. PubMed ID: 18569753
[TBL] [Abstract][Full Text] [Related]
26. The cigarette controversy.
Cummings KM; Brown A; O'Connor R
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1070-6. PubMed ID: 17548665
[TBL] [Abstract][Full Text] [Related]
27. Ashes to ashes: why FDA regulation of tobacco advertising may mark the end of the road for the Marlboro man.
Paralusz KM
Am J Law Med; 1998; 24(1):89-122. PubMed ID: 9607105
[No Abstract] [Full Text] [Related]
28. A century of smoke.
Yach D; Wipfli H
Ann Trop Med Parasitol; 2006; 100(5-6):465-79. PubMed ID: 16899149
[TBL] [Abstract][Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
